Current Alzheimer disease research highlights: evidence for novel risk factors

Alzheimer’s disease (AD) affects over 55 million people worldwide, and that number is expected to triple by 2050. For decades, research focused on amyloid-beta (Aβ) and tau—proteins that clump in the brains of AD patients—but no treatments have stopped or reversed the disease. Now, scientists are shifting focus to everyday factors that might raise or lower risk: sleep, oxygen levels, diet, gut health, and hearing. A 2021 review by researchers from the University of California, San Francisco (UCSF), Sichuan Provincial People’s Hospital, and Queen’s University Belfast highlights how these understudied areas could hold keys to preventing or delaying AD.

Sleep: A bidirectional link to AD

Sleep problems—insomnia, sleep apnea, or disrupted circadian rhythms—are common in AD patients, worsening quality of life and accelerating institutionalization. But emerging research shows a two-way relationship: sleep disturbances may also contribute to AD.

Studies link poor sleep to a 50–80% higher risk of dementia. For example, short (under 6 hours) or long (over 9 hours) sleep duration, excessive napping, and sleep apnea are all tied to faster cognitive decline. One Nature Human Behaviour study found 23 sleep metrics—like rapid eye movement (REM) duration and brain wave patterns—strongly predict cognitive performance in older adults.

Why? During deep sleep, the brain clears waste (including Aβ and tau) via the glymphatic system. Sleep deprivation reduces this clearance, letting toxins build up. Animal studies show sleep loss increases Aβ production and tau spread, while human studies link poor sleep to faster Aβ accumulation in the brain.

Interventions like cognitive behavioral therapy for insomnia (CBT-I) or continuous positive airway pressure (CPAP) for sleep apnea show promise in small trials. But researchers still debate: Are sleep problems causes of AD, or early signs of brain changes? Either way, improving sleep is a low-risk way to support brain health.

Hypoxia: Low oxygen fuels AD pathology

Hypoxia—low oxygen in the brain—can stem from sleep apnea, heart disease, or chronic kidney disease. It’s not just a symptom of poor health: it actively worsens AD.

Animal studies show hypoxia increases Aβ production, reduces its clearance, and boosts tau hyperphosphorylation (the “tangles” that kill neurons). It also triggers inflammation, oxidative stress, and mitochondrial damage—all key drivers of AD.

Hyperbaric oxygen therapy (HBOT)—breathing pure oxygen in a pressurized chamber—has emerged as a potential treatment. Small studies find HBOT improves cognitive function in AD patients and reduces Aβ in mouse models. It also increases telomere length (a marker of cellular aging) and clears “senescent” (damaged) cells.

But HBOT isn’t a cure. No studies have tested if it prevents AD in high-risk groups, and oxygen toxicity is a concern. More research is needed to confirm its safety and effectiveness.

Diet: The Mediterranean diet and beyond

What you eat affects more than your waistline—it influences your brain. Poor diet (high in sugar, saturated fat) raises risk of AD-linked conditions like diabetes and heart disease. But a Mediterranean-style diet (rich in fruits, veggies, olive oil, nuts, and fish) may lower risk by 40–54% in some studies.

Why? The diet is packed with antioxidants and flavonoids that reduce inflammation and protect neurons. It also feeds “good” gut bacteria, which produce short-chain fatty acids (SCFAs) that support brain health. A 2020 Gut study found the Mediterranean diet alters gut microbiota in older adults, improving cognitive function.

But results are mixed. Some populations (like French or Swedish adults) don’t show the same benefit, possibly due to differences in diet quality or follow-up time. Long-term randomized trials are needed to confirm if the Mediterranean diet prevents AD—or just slows cognitive decline.

Gut microbiota: The “forgotten organ” in AD

The gut and brain communicate via the gut-brain axis—a network of nerves, hormones, and immune signals. In AD, this axis goes haywire: patients have fewer “beneficial” bacteria (like Bifidobacterium) and more pro-inflammatory species (like Enterobacteriaceae). These changes often start years before dementia symptoms appear.

Gut bacteria produce metabolites that reach the brain:

TMAO: A byproduct of red meat digestion that increases inflammation.
SCFAs: Made from fiber, SCFAs reduce Aβ and protect neurons.
Bile acids: Imbalanced in AD, these affect brain glucose metabolism and atrophy.

Probiotics (like Lactobacillus or Bifidobacterium) and fecal microbiota transplantation (FMT) have shown promise in mice—reducing Aβ, tau, and inflammation. A 2021 J Gerontol trial found probiotics improved cognitive function in healthy older adults. But in severe AD, probiotics don’t help—suggesting timing matters.

Diet is key here too: the Mediterranean diet and fiber-rich foods feed beneficial bacteria. But researchers still don’t know which specific bacteria (or combinations) protect against AD.

Hearing loss: A silent risk factor

Nearly 40% of adults over 65 have hearing loss—and it’s strongly linked to dementia. Observational studies find hearing-impaired older adults are 2–3 times more likely to develop AD.

Why? Hearing loss forces the brain to work harder to process sound, draining resources from memory and thinking. It also reduces social engagement—loneliness is a known AD risk factor. Animal studies show noise-induced hearing loss damages the hippocampus (a brain region for memory) and reduces neurogenesis (new neuron growth).

The 2020 Lancet Commission on Dementia estimates treating hearing loss could reduce global dementia burden by 8%. But evidence from clinical trials is mixed: hearing aids improve quality of life but don’t always slow cognitive decline in AD patients.

Even so, treating hearing loss is critical. It’s one of the few modifiable risk factors with immediate benefits for quality of life—and it may help preserve brain health over time.

What’s next?

AD research is at a crossroads. For years, focus on amyloid and tau yielded no breakthroughs. Now, scientists are looking at systemic factors—sleep, oxygen, diet, gut health, hearing—that interact with the brain to drive disease.

The takeaways are clear:

Sleep well (7–8 hours, consistent schedule) to support waste clearance.
Protect your heart and lungs to avoid hypoxia.
Eat a plant-rich, Mediterranean-style diet to feed your gut and brain.
Treat hearing loss early to stay socially connected.

But many questions remain: Do these factors cause AD, or are they symptoms? Which interventions work best for which people? How do they interact (e.g., does diet improve sleep, which in turn reduces Aβ)?

The 2021 review’s authors emphasize that AD isn’t a single disease—it’s a “heterogeneous” condition driven by multiple factors. The future of AD research lies in prevention—targeting these lifestyle factors before symptoms appear.

For now, the best advice is simple: Take care of your whole body. Your brain will thank you.

doi.org/10.1097/CM9.0000000000001706

Was this helpful?

0 / 0